TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
 
 
C07D HETEROCYCLIC COMPOUNDS 6156
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
 
 
C07G COMPOUNDS OF UNKNOWN CONSTITUTION 19

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9840494 Quinazoline derivativeDec 12, 14Dec 12, 17[C07D]
9676724 Cyanoquinoline derivativesOct 12, 15Jun 13, 17[C07D]
9670242 Tetracyclic anthraquinone derivativesMar 06, 13Jun 06, 17[C07H, A01N, C07G, A61K]
9187458 Cyanoquinoline derivativesJun 08, 11Nov 17, 15[C07D, A61P, A61K]
9115165 Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the same and use thereofApr 09, 09Aug 25, 15[C07H, A61P, A61K]
8765946 Methods of preparing and using quinazoline and quinoline derivativesMay 11, 12Jul 01, 14[C07D]
8604065 Pyridyl cyanoguanidine derivativesNov 18, 10Dec 10, 13[C07D, C07C, A61K]
8198301 Quinazoline and quinoline derivatives as irreversibe protein tyrosine kinase inhibitorsMay 26, 10Jun 12, 12[A61K]
7754729 Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitorsDec 23, 08Jul 13, 10[A61K]

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.